Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Chris Reed to Speak on Panel at the Maxim Group Health, Wellness & Better Eating Conference
-
Keryx Biopharmaceuticals (KERX) PT Rasied to $7 at Maxim Group Following Positive Study
-
BioPharmX (BPMX) Prices $4.3M Common Stock, Warrants Offering
-
BioPharmX Corporation Announces Pricing Of Public Offering To Raise $4.3 Million
-
Maxim Group Raises Price Target on Adamis Pharmaceuticals (ADMP) Following Announced US Compounding Acquisition
-
BioPharmX (BPMX) Plans Common Stock, Warrants Offering
-
BioPharmX Corporation Announces Proposed Public Offering of Common Stock and Warrants
-
Quantum Genomics Raises €8.6 Million in U.S. and Europe
-
Maxim Group Downgrades Chipotle Mexican Grill (CMG) to Sell
-
ContraFect (CFRX) PT Trimmed to $7 at Maxim Group as Results Awaited
-
GEF Acquisition Corporation Files Registration Statement for Initial Public Offering
-
StemCells, Inc. Announces Closing of $8 Million Public Offering
-
Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Maxim Group Upgrades Agenus Inc. (AGEN) to Buy
-
Pre-Open Stock Movers 03/11 (SSKN) (FNSR) (ULTA) Higher; (FXCM) (SGY) (RUN) Lower (more...)
-
Athersys (ATHX) PT Doubled to $10 at Maxim Group
-
StemCells (STEM) Prices $11M Stock, Warrants Offering
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $8.1 Million
-
Maxim Group Starts Determine (DTRM) at Buy
-
StemCells (STEM) to Offer Common Stock and Warrants
-
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
The Alliance for Regenerative Medicine Releases Agenda for Fourth Annual Cell & Gene Therapy Investor Day
-
Jensyn Acquisition Corporation Completes $39.0 Million Initial Public Offering
-
UPDATE: Maxim Group Downgrades NovaBay Pharmaceuticals (NBY) to Hold
-
Dunkin' Donuts to target Starbucks customers after loyalty scheme shake-up
-
Jensyn Acquisition Corp. Announces Pricing of Initial Public Offering
-
Maxim Group Downgrades Benitec BioPharma (BNTC) to Hold
-
Domino's profit boosted as demand holds up in U.S. pizza price war
-
root9B Technologies Receives $1.26 Million In Proceeds From Warrant Exercise Offer
-
RiceBran Technologies Announces Closing of $3 Million Registered Direct Offering
-
Notable Mergers and Acquisitions 2/22: (SYY) (PHMD)/(DSKX) (VZ)
-
PhotoMedex (PHMD) Announces Agreement to Sell Consumer Products, Professional Products Businesses to DS Healthcare (DSKX)
-
DS Healthcare (DSKX) to Acquire Radiancy from PhotoMedex
-
DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Businesses
-
PhotoMedex to Sell Consumer and Professional Businesses to DS Healthcare Group
-
Maxim Group Downgrades Flowserve Corp. (FLS) to Hold
-
Maxim Group Hosts Key Opinion Leaders Discussing “Breakthroughs in Dermatology” Relating to Products From Oculus Innovative Sciences
-
RiceBran Technologies (RIBT) Enters $3M Conv. Preferred Direct Offering
-
RiceBran Technologies Announces $3 Million Registered Direct Offering
-
Blue Sphere Completes "At Market" Financing
-
SpendSmart Networks, Inc. Completes Raise of $2.4 Million Tender Offering
-
Mast Therapeutics Closes $8 Million Public Offering
-
Gilead Sciences (GILD) PT Lowered to $115 at Maxim Group; 'Buy' Maintained
-
Mast Therapeutics (MSTX) Prices 29M Offering of Common Stock and Warrants at $0.275/Unit
-
Mast Therapeutics Announces Pricing Of Underwritten Public Offering
-
Viscount Mining Announces Addition of Seasoned Business Executive to Advisory Board
-
Notable Analyst Rating Changes 2/9: (KGC) (SSNC) (THS) Upgraded; (BRX) (TYG) (MT) Downgraded
-
Maxim Group Starts Cheesecake Factory (CAKE) at Buy
-
Notable Analyst Rating Changes 2/3: (NPTN) (MNK) (SYNT) Upgraded; (MCHP) (XEL) (MS) Downgraded
-
Maxim Group Upgrades Syntel, Inc. (SYNT) to Buy


